Plexus (NASDAQ:PLXS) Releases Q2 2026 Earnings Guidance

by · The Cerbat Gem

Plexus (NASDAQ:PLXS – Get Free Report) updated its second quarter 2026 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 1.800-1.950 for the period, compared to the consensus estimate of 1.630. The company issued revenue guidance of $1.1 billion-$1.2 billion, compared to the consensus revenue estimate of $1.1 billion.

Plexus Stock Performance

Shares of PLXS stock traded up $7.34 during trading on Wednesday, reaching $180.85. The company had a trading volume of 502,968 shares, compared to its average volume of 286,498. The company has a market capitalization of $4.84 billion, a PE ratio of 28.89 and a beta of 0.81. Plexus has a one year low of $103.43 and a one year high of $186.47. The firm’s 50 day simple moving average is $156.61 and its two-hundred day simple moving average is $144.79. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.58 and a quick ratio of 0.77.

Plexus (NASDAQ:PLXS – Get Free Report) last issued its earnings results on Wednesday, January 28th. The technology company reported $1.78 earnings per share for the quarter, beating the consensus estimate of $1.77 by $0.01. Plexus had a net margin of 4.29% and a return on equity of 12.77%. The business had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.07 billion. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. Sell-side analysts forecast that Plexus will post 5.9 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on PLXS shares. Benchmark upped their price target on Plexus from $165.00 to $195.00 and gave the stock a “buy” rating in a research note on Wednesday. Williams Trading set a $195.00 price objective on shares of Plexus in a report on Wednesday. Wall Street Zen downgraded shares of Plexus from a “buy” rating to a “hold” rating in a report on Saturday, November 22nd. Stifel Nicolaus set a $150.00 price objective on Plexus in a report on Friday, October 24th. Finally, Needham & Company LLC increased their target price on Plexus from $158.00 to $165.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. Two investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $171.00.

View Our Latest Report on PLXS

Insiders Place Their Bets

In related news, Director Karen Marie Rapp sold 500 shares of the firm’s stock in a transaction dated Friday, November 28th. The shares were sold at an average price of $143.47, for a total value of $71,735.00. Following the completion of the sale, the director owned 7,665 shares in the company, valued at $1,099,697.55. This trade represents a 6.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Todd P. Kelsey sold 2,000 shares of the company’s stock in a transaction dated Tuesday, November 4th. The shares were sold at an average price of $143.50, for a total transaction of $287,000.00. Following the completion of the transaction, the chief executive officer owned 60,714 shares in the company, valued at approximately $8,712,459. This trade represents a 3.19% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 9,674 shares of company stock valued at $1,382,876. Corporate insiders own 1.78% of the company’s stock.

Plexus News Summary

Here are the key news stories impacting Plexus this week:

  • Positive Sentiment: Management set Q2 FY2026 revenue and non‑GAAP EPS guidance above Street consensus (revenue $1.110–$1.150B; non‑GAAP EPS $1.80–$1.95), signaling accelerating sequential growth. Quiver Quant – Q1 Results & Guidance
  • Positive Sentiment: Q1 non‑GAAP EPS of $1.78 narrowly topped estimates and revenue of $1.07B showed 10% YoY growth, providing validation for management’s recovery thesis. Zacks – Plexus Beats Q1 Estimates
  • Positive Sentiment: Plexus won 22 new manufacturing programs with ~$283M of annualized revenue potential (not yet fully ramped), including record Aerospace/Defense program wins — a catalyst for future revenue and margin expansion. Quiver Quant – Program Wins
  • Positive Sentiment: Benchmark raised its price target to $195 and kept a Buy rating, providing analyst support that can sustain investor interest. The Fly – Price Target Raised
  • Neutral Sentiment: Plexus repurchased $22.4M of shares under its $100M program (≈$62.6M remaining), a shareholder‑friendly action but modest in scale relative to market cap. Quiver Quant – Buybacks
  • Neutral Sentiment: Company emphasizes non‑GAAP metrics (adjusted EPS/margins) — useful for operating trends but requires care because GAAP and non‑GAAP ranges differ. GlobeNewswire – Press Release
  • Negative Sentiment: Q1 showed negative free cash flow (~$50.6M) and a lengthening cash cycle (69 days) due to working‑capital investments to support ramps — near‑term cash use could pressure liquidity or limit larger buybacks/dividends. Quiver Quant – Cash Flow & Cash Cycle
  • Negative Sentiment: Significant insider selling activity was reported (multiple executive sales), which investors sometimes view as a negative signal. Quiver Quant – Insider Activity

Institutional Investors Weigh In On Plexus

A number of institutional investors have recently modified their holdings of PLXS. Johnson Financial Group Inc. bought a new stake in shares of Plexus in the 3rd quarter valued at $72,000. EverSource Wealth Advisors LLC raised its position in shares of Plexus by 583.3% in the second quarter. EverSource Wealth Advisors LLC now owns 574 shares of the technology company’s stock valued at $78,000 after buying an additional 490 shares in the last quarter. Corient Private Wealth LLC acquired a new stake in shares of Plexus during the 2nd quarter worth approximately $210,000. United Services Automobile Association acquired a new position in Plexus during the 1st quarter worth approximately $218,000. Finally, Blair William & Co. IL bought a new position in shares of Plexus during the third quarter valued at $259,000. Institutional investors and hedge funds own 94.45% of the company’s stock.

Plexus Company Profile

(Get Free Report)

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.

Featured Stories